Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors
- DOI
- 10.1080/2162402x.2024.2412371
- Published
- 2024-10-03
- Container
- OncoImmunology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/2162402x.2024.2412371,
title = {Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors},
author = {Christian Pellegrino and Nicholas Favalli and Laura Volta and Ramon Benz and Sara Puglioli and Gabriele Bassi and Kathrin Zitzmann and Christoph Josef Auernhammer and Svenja Nölting and Chiara F. Magnani and Dario Neri and Felix Beuschlein and Markus G. Manz},
year = {2024},
journal = {OncoImmunology},
doi = {10.1080/2162402x.2024.2412371},
url = {https://doi.org/10.1080/2162402x.2024.2412371}
}RIS
TY - JOUR TI - Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors AU - Christian Pellegrino AU - Nicholas Favalli AU - Laura Volta AU - Ramon Benz AU - Sara Puglioli AU - Gabriele Bassi AU - Kathrin Zitzmann AU - Christoph Josef Auernhammer AU - Svenja Nölting AU - Chiara F. Magnani AU - Dario Neri AU - Felix Beuschlein AU - Markus G. Manz PY - 2024 JO - OncoImmunology DO - 10.1080/2162402x.2024.2412371 UR - https://doi.org/10.1080/2162402x.2024.2412371 ER -
APA
Pellegrino, C., Favalli, N., Volta, L., Benz, R., Puglioli, S., Bassi, G., Zitzmann, K., Auernhammer, C. J., Nölting, S., Magnani, C. F., Neri, D., Beuschlein, F., & Manz, M. G. (2024). Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors. OncoImmunology. https://doi.org/10.1080/2162402x.2024.2412371
Source records
- crossref · retrieved 2026-09-26T04:03:11.570Z